Source comparison
CJC-1295 Variant Comparison — DAC vs No DAC
Plasma Half-Life 6–8 days ~30 minutes No DAC: acute pulse studies; DAC: sustained elevation models GH Elevation Pattern Sustained baseline increase (2–3× normal for days) Transient pulse (200–300% spike, returns to baseline in 2–3 hours) No DAC mirrors physiol
This comparison does not assign a generated winner or score.
- Plasma Half-Life
- 6–8 days
- ~30 minutes
- No DAC: acute pulse studies; DAC: sustained elevation models
- GH Elevation Pattern
- Sustained baseline increase (2–3× normal for days)
- Transient pulse (200–300% spike, returns to baseline in 2–3 hours)
- No DAC mirrors physiological pulses; DAC creates supra-physiological steady state
- Dosing Frequency
- Once weekly
- Multiple times daily (6–12 hour intervals)
- No DAC requires protocol adherence; DAC allows flexible timing
- Albumin Binding
- High (Drug Affinity Complex modification)
- Minimal (no DAC modification)
- DAC extends circulation; no DAC clears rapidly via renal filtration
- Receptor Desensitisation Risk
- Moderate (chronic GHRH-R activation)
- Low (pulsatile activation allows receptor recycling)
- No DAC preserves receptor sensitivity long-term; DAC may blunt response over weeks
- Blood Sampling Window
- Flexible (elevated GH persists across days)
- Narrow (must capture 30-minute peak or miss response entirely)
- No DAC demands precise timing; DAC tolerates sampling variability